Amphix Bio
Business Services · Illinois, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
400 N Aberdeen St Ste 900, Chicago, Illi...Website
www.amphixbio.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Amphix Bio
Amphix Bio is developing a new platform technology, Supramolecular Therapeutic Peptides (STPs), that modifies immunological response and initiates regenerative processes to restore function lost from injury, disease, or aging. These therapies trigger targeted signaling pathways while forming scaffolds to support biological repair. Amphix Bio's goal is to increase human healthspan the length of time that people can live productive, fulfilling lives.Explore more
Amphix Bio Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Amphix Bio your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Amphix Bio has new funding data
Website visits: Recent activity has been detected on your website
Click to see if Amphix Bio had a recent Job posting/layoffs
Amphix Bio, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Amphix Bio recently announced quarterly report
Check if Amphix Bio has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Amphix Bio launches new products
Check out if Amphix Bio is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Amphix Bio
Recommended Actions
Find VP level buyers at Amphix Bio
Find 3 more new buyers
Compare Similar Companies to Amphix Bio
Compare insights from companies similar to Amphix Bio, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Amphix Bio is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Amphix Bio is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Amphix Bio.
Amphix Bio financials insights
Gather financial insights about Amphix Bio, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2024
Grant
$1M
2025
Seed
$12.5M
Amphix Bio Tech Stack
A closer look at the technologies used by Amphix Bio
Most Recent Scoops
Funding
Funding
Funding
Project
Spending/Investment, Funding
Funding
Funding
Funding
Amphix Bio News & Media
Amphix Bio raises $12.5M seed round to advance peptide drug platform
CHICAGO, Dec. 18, 2025 /PRNewswire/ -- Amphix Bio today announced the initial closing of a $12.5 million seed financing round to advance its lead therapeutic candidates toward human clinical trials and expand its pipeline to target additional neurological conditions. The funding comes...Amphix Bio receives FDA Orphan Drug Designation for neural regeneration therapeutic to treat acute spinal cord injury
CHICAGO, July 16, 2025 /PRNewswire/ -- Amphix Bio, a pre-clinical stage company developing a new therapeutic modality for regenerative medicine, received an Orphan Drug Designation from the U.S. Food and Drug Administration (FDA) for its lead candidate AMFX-200 for treatment of acute...Amphix Bio lands federal and state grants to manufacture regenerative therapies
CHICAGO, Oct. 31, 2024 /PRNewswire/ -- Amphix Bio, a company developing a new class of regenerative medicine therapies, announced that it has secured a $1M Small Business Innovation Research (SBIR) Phase II grant from the National Science Foundation (NSF) to scale up manufacturing methods...FDA grants Breakthrough Device designation to Amphix Bio's bone regeneration product
CHICAGO, Oct. 3, 2024 /PRNewswire/ -- Amphix Bio, a company developing a new class of regenerative medicine therapies, announced today it has received a Breakthrough Device designation from the U.S. Food and Drug Administration (FDA) for a drug-device combination product for bone...
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Frequently Asked Questions Regarding Amphix Bio
Sign Up For FreeTo access detailed company insights
Amphix Bio is developing a new platform technology, Supramolecular Therapeutic Peptides (STPs), that modifies immunological response and initiates regenerative processes to restore function lost from injury, disease, or aging. These therapies trigger targeted signaling pathways while forming scaffolds to support biological repair. Amphix Bio's goal... Read More
